BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo
← Back to IPO overview
Paras Healthcare logo

Mainboard IPO

Paras Healthcare IPO

ListedBSE, NSE

Prices in INR · Times in IST

GMP updated: 28 Oct 2026, 08:24 AM IST

Price band
₹660 – ₹693
Application estimate
₹14,5531 lot(s) · 21 sh
GMP · unofficial
₹13 (+1.88%)
Est. listing price
₹706Issue price + GMP
Issue size
₹1,450 Cr
Total subscription
2.23×

GMP trend & intraday history

28 Oct 2026
₹13+1.88%₹0 vs previous
Est. profit (1 lot · 21 sh)₹273
Issue price + GMP₹706
9652.5914 Oct 2026: ₹8315 Oct 2026: ₹8516 Oct 2026: ₹9517 Oct 2026: ₹9618 Oct 2026: ₹9219 Oct 2026: ₹7820 Oct 2026: ₹5021 Oct 2026: ₹2522 Oct 2026: ₹1323 Oct 2026: ₹1124 Oct 2026: ₹1225 Oct 2026: ₹926 Oct 2026: ₹1127 Oct 2026: ₹1328 Oct 2026: ₹1314 Oct 202628 Oct 2026

Hover or tap on the chart to inspect a reading. Dates use calendar spacing; large gaps are not connected.

High in this view
₹96 (₹2,016)
Low in this view
₹9 (₹189)
Reference issue price
₹693
Readings in this view
15
Subject to sauda
300 / 4200
GMP source readings
ReadingGMPPremium %Issue price + GMPEst. profit (1 lot · 21 sh)Subject to sauda
14 Oct 2026₹83—₹776₹1,743—
15 Oct 2026₹85(+12.27%)₹778₹1,7851800 / 25200
16 Oct 2026₹95(+13.71%)₹788₹1,9951500 / 21000
17 Oct 2026₹96(+13.85%)₹789₹2,0161500 / 21000
18 Oct 2026₹92(+13.28%)₹785₹1,9321500 / 21000
19 Oct 2026₹78(+11.26%)₹771₹1,6381500 / 21000
20 Oct 2026₹50(+7.22%)₹743₹1,050800 / 11200
21 Oct 2026₹25(+3.61%)₹718₹525400 / 5600
22 Oct 2026₹13(+1.88%)₹706₹273200 / 2800
23 Oct 2026₹11(+1.59%)₹704₹2310
24 Oct 2026₹12(+1.73%)₹705₹2520
25 Oct 2026₹9(+1.3%)₹702₹189200 / 2800
26 Oct 2026₹11(+1.59%)₹704₹231200 / 2800
27 Oct 2026₹13(+1.88%)₹706₹273300 / 4200
28 Oct 2026₹13(+1.88%)₹706₹273300 / 4200

Issue at a glance

Issue Size₹1,450 Cr
Price Band₹660 – ₹693
Final Issue Price₹693
Face Value₹1
Lot Size21 Shares
Employee Discount—
Issue TypeFresh capital and offer for sale
Listing ExchangesBSE, NSE
NSE SymbolPARASHLTH.NS
BSE Scrip Code8048

IPO timetable & schedule

Completed IPO lifecycleListed · 28 Oct 2026
IPO Open Date
Bidding opens
IPO Close Date
Bidding closes
Basis of Allotment
Allotment finalisation
Initiation of Refunds
Unallotted funds unblocked
Credit of Shares to Demat
Shares credited to demat
Tentative Listing Date
Exchange listing (BSE / NSE)

Subscription by investor category

Source updated: 28 Oct 2026, 06:30 PM IST

Overall Demand: 2.23×
QIB (Institutional)3.09×
Bid: 20381592Offered: 6590908
NII / HNI0.66×
Bid: 2166507Offered: 3295454
Retail (Individual)2×
Bid: 4395615Offered: 2196969
Employee0×
Bid: 0Offered: —
Shareholder0×
Bid: 0Offered: —
Investor categoryTimes subscribedShares offeredShares bidApplicationsDemand (₹ crore)
Qualified Institutional Buyers (QIB)3.09×65909082038159227₹1412.44 Cr
↳ Foreign Institutional Investors——7130235—₹494.13 Cr
↳ Domestic Financial Institutions——688968—₹47.75 Cr
↳ Mutual Funds——10389540—₹720 Cr
↳ Others——2172849—₹150.58 Cr
Non-Institutional Investors (NII)0.66×329545421665073169₹150.14 Cr
↳ bNII — bids above ₹10 Lakh0.59×21969701289883716₹89.39 Cr
↳ bNII — Corporates——113043—₹7.83 Cr
↳ bNII — Individuals——1147734—₹79.54 Cr
↳ bNII — Others——29106—₹2.02 Cr
↳ sNII — bids ₹2 Lakh to ₹10 Lakh0.8×10984848766242453₹60.75 Cr
↳ sNII — Corporates——9408—₹0.65 Cr
↳ sNII — Individuals——846195—₹58.64 Cr
↳ sNII — Others——21021—₹1.46 Cr
Retail Individual Investors (RII)2×21969694395615143377₹304.62 Cr
↳ Cut-off price bids——3930360—₹272.37 Cr
↳ Price bids——465255—₹32.24 Cr
Employee0×—0—₹0 Cr
↳ Cut-off price bids—————
↳ Price bids—————
Shareholder0×—0—₹0 Cr
↳ Cut-off price bids—————
↳ Price bids—————
Total2.23×1208333126943714146573₹1867.2 Cr

Mainboard figures are consolidated. NSE and BSE demand is not added together. Rupee demand is calculated from bid shares and the cap price; it is not an exchange-published amount. Application source: boa.

QIB funding cost illustration

Arithmetic for a fully funded institutional bid over 7 days; not a recommendation or a retail return estimate.

Days
7
Interest Rate
Not published
Cost Per Share
2141.37

Day-wise subscription history

One snapshot near each bidding day’s close. This is not a continuous intraday series.

DayDateTime (IST)QIBNIIRetailEmployeeShareholderTotal
121 Oct 202619:50:050×0.08×0.69×0×0×0.15×
222 Oct 202619:50:110.06×0.25×1.31×0×0×0.34×
323 Oct 202619:50:073.09×0.66×2×0×0×2.23×

Plan your application

APPLICATION REFERENCE
Listed 28 Oct 2026
Minimum application estimate₹14,5531 lot · At upper band

Estimate uses the published lot size and upper price band. Confirm your category and the offer terms before applying.

21 shares × ₹693₹14,553

One lot: ₹14,553 · Allocation is not guaranteed. Broker cut-off times may differ.

Source-published application tiers
Source categoryLotsSharesAmount
Retail (Min)121₹14,553
Retail (Max)13273₹1,89,189
S-HNI (Min)14294₹2,03,742
B-HNI (Min)691449₹10,04,157
Before you place an IPO application
  1. Read the issue. Check the offer document, business risks, price band and your application category.
  2. Apply through your broker or bank. Use your existing broker’s IPO section or your bank’s ASBA facility. This page does not submit a bid.
  3. Check the payment step. If using UPI, confirm the mandate in your UPI app and check that the funds are blocked. A saved bid alone is not confirmation.
  4. Track what happens next. Keep your application number. Use the registrar’s official page for allotment and the published timeline for refunds, demat credit and listing.

GMP return scenario

What could this amount look like?

GMP-based scenario · Not a forecast

Application amount₹14,55321 shares
GMP-based gain / loss₹273+1.88%
Illustrative value₹14,826Before fees and taxes

Assumes all requested shares are allotted and listing equals issue price + GMP. Actual allotment, listing price, fees and taxes can change the result.

Your IPO progress

Keep your own record of this IPO. Statuses are entered by you, not verified with a broker or registrar. Saved on this browser for your signed-in account; not synced across devices.

IPO reservation & shares offered

Investor CategoryAllocation / Reservation
QIB1,56,92,640 shares (75.00% of the Offer)
NII31,38,528 shares (15.00% of the Offer)
Retail20,92,352 shares (10.00% of the Offer)

Shares offered by category

QIB Shares Offered6590908
NII (HNI) Shares Offered3295454
Retail Shares Offered2196969

Category-wise allocation percentages follow SEBI ICDR norms as stated in the offer document.

Promoter holding & ownership

Pre-Issue Holding72.80%
Post-Issue Holding63.95%

Dr. Dharminder Kumar Nagar

Dr. Dharminder Kumar Nagar holds 7,35,19,238 shares or 72.80% of the pre-offer paid up equity share capital, and the two promoter group members, Gurdeep Kaur Nagar and Ranya Nagar, hold one share each. Commelina Ltd holds 16.44% and the 360 ONE funds together hold just over 7%.

Anchor investors & allocations

Anchor entities
39
Total allocation (₹ crore)
652.5
Mutual fund allottees
24
Official allocation document
Anchor document: not published

Investor allocations

InvestorFund houseSharesAmount (₹ crore)% of anchor book% of issue
SBI MULTI ASSET ALLOCATION FUNDSBI MUTUAL FUND937923659.96%4.48%
SBI INFRASTRUCTURE FUNDSBI MUTUAL FUND721497507.66%3.45%
SBI HEALTHCARE OPPORTUNITIES FUNDSBI MUTUAL FUND505050355.36%2.41%
SBI BALANCED HYBRID FUNDSBI FUNDS432894304.6%2.07%
SBI DIVIDEND YIELD FUNDSBI MUTUAL FUND288603203.07%1.38%
HDFC MULTI-ASSET FUNDHDFC MUTUAL FUND750335.20.8%0.36%
HDFC BUSINESS CYCLE FUNDHDFC MUTUAL FUND750335.20.8%0.36%
HDFC SMALL CAP FUNDHDFC MUTUAL FUND38094026.44.05%1.82%
HDFC INFRASTRUCTURE FUNDHDFC MUTUAL FUND461793.20.49%0.22%
HDFC PHARMA & HEALTHCARE FUNDHDFC MUTUAL FUND288603203.07%1.38%
ISIF HYBRID LONG-SHORT FUNDICICI PRUDENTIAL MUTUAL FUND144291101.53%0.69%
ISIF EQUITY LONG-SHORT FUNDICICI PRUDENTIAL MUTUAL FUND7215650.77%0.34%
ICICI PRUDENTIAL EXPORTS & SERVICES FUNDICICI PRUDENTIAL MUTUAL FUND216447152.3%1.03%
KOTAK CONTRA FUNDKOTAK MAHINDRA MUTUAL FUND216447152.3%1.03%
KOTAK HEALTHCARE FUNDKOTAK MAHINDRA MUTUAL FUND216447152.3%1.03%
ABU DHABI INVESTMENT AUTHORITY-STABLEABU DHABI INVESTMENT10100587010.73%4.83%
BLACKROCK GLOBAL FUNDS - INDIA FUNDBLACKROCK33847823.463.59%1.62%
BLACKROCK GLOBAL FUNDS-ASIAN DRAGON FUNDBLACKROCK34694124.043.68%1.66%
WHITEOAK CAPITAL MID CAP FUNDWHITEOAK CAPITAL MUTUAL FUND274176192.91%1.31%
WHITEOAK CAPITAL MULTI CAP FUNDWHITEOAK CAPITAL MUTUAL FUND937866.51%0.45%
WHITEOAK CAPITAL PHARMA & HEALTHCARE FUNDWHITEOAK CAPITAL MUTUAL FUND10101071.07%0.48%
WHITEOAK CAPITAL MULTI ASSET ALLOCATION FUNDWHITEOAK CAPITAL MUTUAL FUND360782.50.38%0.17%
WHITEOAK CAPITAL EQUITY FUNDWHITEOAK CAPITAL MUTUAL FUND7215650.77%0.34%
WHITEOAK CAPITAL EQUITY FUND-IIWHITEOAK216426152.3%1.03%
EASTSPRING INVESTMENTS-UNIT TRUST-DRAGON PEACOCK FUNDEASTSPRING288582203.06%1.38%
GOVERNMENT PENSION FUND GLOBALGOVERNMENT PENSION FUND GLOBAL216447152.3%1.03%
NATIXIS INTERNATIONAL FUNDS (LUX) I-LOOMIS SAYLES GLOBAL EMERGING MARKETS EQUITY FUNDNATIXIS216468152.3%1.03%
ICICI PRUDENTIAL LIFE INSURANCE CO.LTD.ICICI PRUDENTIAL LIFE INSURANCE505050355.36%2.41%
MOTILAL OSWAL CONSUMPTION FUNDMOTILAL OSWAL MUTUAL FUND144312101.53%0.69%
EDELWEISS EQUITY SAVINGS FUNDEDELWEISS MUTUAL FUND7215650.77%0.34%
EDELWEISS RECENTLY LISTED IPO FUNDEDELWEISS MUTUAL FUND7215650.77%0.34%
360 ONE PRIVATE EQUITY FUND-SERIES II360 ONE144312101.53%0.69%
BARODA BNP PARIBAS HEALTH & WELLNESS FUNDBARODA BNP PARIBAS MUTUAL FUND7220150.77%0.35%
ITI ELSS TAX SAVER FUNDITI MUTUAL FUND7215650.77%0.34%
EDELWEISS LIFE INSURANCE CO.LTD.EDELWEISS LIFE INSURANCE7215650.77%0.34%
CANARA HSBC LIFE INSURANCE CO.LTD.CANARA HSBC7215650.77%0.34%
INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD.INTEGRATED CORE144312101.53%0.69%
SUSQUEHANNA PACIFIC PTY.LTD.SUSQUEHANN144312101.53%0.69%
CITIGROUP GLOBAL MARKETS MAURITIUS PVT.LTD.CITIGROUP7215650.77%0.34%

By fund house

Fund houseAnchorsAmount (₹ crore)
SBI MUTUAL FUND4170
ABU DHABI INVESTMENT170
HDFC MUTUAL FUND560
BLACKROCK247.5
WHITEOAK CAPITAL MUTUAL FUND540
ICICI PRUDENTIAL LIFE INSURANCE135
SBI FUNDS130
ICICI PRUDENTIAL MUTUAL FUND330
KOTAK MAHINDRA MUTUAL FUND230
EASTSPRING120
WHITEOAK115
GOVERNMENT PENSION FUND GLOBAL115
NATIXIS115
MOTILAL OSWAL MUTUAL FUND110
EDELWEISS MUTUAL FUND210
360 ONE110
INTEGRATED CORE110
SUSQUEHANN110
BARODA BNP PARIBAS MUTUAL FUND15
ITI MUTUAL FUND15
EDELWEISS LIFE INSURANCE15
CANARA HSBC15
CITIGROUP15

Financials & valuation

Figures in Rs. Crore · Changes compare matching annual period-end dates only.

Revenue from Operations
—Latest: 30 Jun 2026Prior (31 Mar 2026): 1,605.95 · YoY unavailable
Profit After Tax
49.68Latest: 30 Jun 2026Prior (31 Mar 2026): 43.83 · YoY unavailable
EBITDA
113.48Latest: 30 Jun 2026Prior (31 Mar 2026): 335.58 · YoY unavailable
Total Borrowing
1,429.49Latest: 30 Jun 2026Prior (31 Mar 2026): 1,393.86 · YoY unavailable
Financial performance
Revenue from Operations · Rs. Crore₹1,605.95
Positive
1,129.04
31 Mar '24
1,294.06
31 Mar '25
1,605.95
31 Mar '26
—
30 Jun '26

Rs. Crore

Metric30 Jun 202631 Mar 202631 Mar 202531 Mar 2024
Revenue from Operations1605.951294.061129.04
Assets2,202.882,071.141,810.451,477.66
Total Income478.751,628.781,314.211,151.02
Profit After Tax49.6843.83-57.98-15.33
EBITDA113.48335.58156.46154.41
NET Worth444.96394.94280.49338.51
Reserves and Surplus434.86384.84270.73328.75
Total Borrowing1,429.491,393.861,232.12923.92

Key valuation & financial KPIs

P/E Ratio
37.72
EPS (₹)
18.37
RoE
11.83%
RoCE
4.23%
RoNW
11.83%
PAT Margin
10.38%
EBITDA Margin
23.70%
Debt / Equity
3.21
NAV (₹)
44.06

What does the company do?

Paras Healthcare Limited is a clinical specialty-led hospital platform that provides tertiary and quaternary healthcare through a network of eight hospitals with an aggregate capacity of 2,211 beds as on 31 March 2026. It operates under the Paras Health brand and is based at Paras Twin Towers, Golf Course Road, Sector 54, Gurugram, Haryana. Its critical care infrastructure includes organ and condition-specific ICUs, with 559 ICU beds as on 31 March 2026, up from 425 beds in FY2024. The hospitals employed 1,011 doctors and 1,665 nurses on the same date. The hospitals are spread over five states and one union territory. They are in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand and Srinagar in Jammu and Kashmir. The Gurugram hospital has run for 20 years and the Patna hospital for 12 years, while the newest units at Srinagar and Kanpur have run for three years and two years. Of the eight, four are super-specialty tertiary care hospitals and four are multi-specialty tertiary care hospitals. Six of the eight run on leased premises, five through revenue share arrangements and long-term leases and one under a public private partnership. The business is reported as a single healthcare services segment in a single geography. Work is concentrated in what the company calls CONGOR specialties, meaning cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences. Together these gave 74.70% of FY2026 revenue from operations, led by oncology at 21.63%, neuro sciences at 13.03% and cardiac sciences at 12.78%. Hospitals outside Gurugram, which the company counts as tier 2 cities, gave 68.18% of FY2026 revenue against 62.35% in FY2024. Operating metrics improved in FY2026. Operational beds rose to 1,502 from 1,465, the bed occupancy rate rose to 61.75% from 50.78%, and occupied bed days rose to 3,38,321 from 2,68,927. In-patient volumes were 1,15,496 and out-patient volumes 7,78,707 in FY2026, against 81,047 and 5,69,139 in FY2024, and the hospitals performed 39,687 surgeries. Average revenue per occupied bed was Rs 47,397.82 per day in FY2026, with the Gurugram hospital at Rs 70,925.76 per day and the Darbhanga hospital at Rs 19,980.75 per day. Average length of stay was 2.93 days. Payments come from three sources. Government schemes and public sector undertakings accounted for 41.28% of FY2026 revenue, self pay patients 33.88% and insurance and third party administrators 24.84%. In FY2024 the same shares were 29.76%, 40.63% and 29.61%. The promoter is Dr. Dharminder Kumar Nagar, the Managing Director, who has been with the company since 2003 and has over 22 years of experience in healthcare. He holds an MBBS from the University of Mysore and a master of philosophy in hospital and health systems management from BITS Pilani.

More about the business

Paras Healthcare runs eight tertiary and quaternary care hospitals under the Paras Health brand, with 2,211 beds across five states and one union territory. Revenue from operations grew 24.10% to Rs 1,605.95 crore in FY2026 and the company reported a profit of Rs 43.83 crore after two years of losses.

Where will the money go?

Use of proceedsAmount (₹ crore)
Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings of the company320.9
Investment in wholly owned subsidiary Plus Medicare Hospitals Private Limited, which runs the Srinagar hospital, for repayment or prepayment of its borrowings54.1
General corporate purposes—

Strengths & risks

Business strengths

  • Revenue from operations grew 24.10% to Rs 1,605.95 crore in FY2026, after 14.62% growth in FY2025.
  • The company turned profitable in FY2026 with a profit of Rs 43.83 crore, against a loss of Rs 57.98 crore in FY2025 and a loss of Rs 15.33 crore in FY2024.
  • EBITDA grew 114.48% from Rs 156.46 crore in FY2025 to Rs 335.58 crore in FY2026.
  • The bed occupancy rate rose to 61.75% in FY2026 from 50.78% in FY2025, with Gurugram at 83.85% and Patna at 73.16%.
  • For the quarter ended 30 June 2026 the source lists return on equity of 11.83% and return on capital employed of 4.23%. These are on one quarter's profit and are not annualised.
  • Volumes are growing across the network. In-patient volumes rose to 1,15,496 in FY2026 from 81,047 in FY2024 and out-patient volumes to 7,78,707 from 5,69,139, with 39,687 surgeries in FY2026.
  • ICU capacity grew to 559 beds as on 31 March 2026 from 425 beds in FY2024, supporting the high-acuity work that gives 74.70% of revenue.
  • Cash flow from operations was Rs 163.51 crore in FY2026 against Rs 86.19 crore in FY2025, so the operating profit is converting into cash.

Risks to understand

  • The profit record is short. The company lost Rs 57.98 crore in FY2025 and Rs 15.33 crore in FY2024, and FY2026 is its first profitable year of the three shown, with a profit margin of only 2.69% of total income.
  • Two subsidiaries, Paras Healthcare (Ranchi) and Plus Medicare Hospitals, together lost Rs 52.09 crore in FY2026, Rs 82.24 crore in FY2025 and Rs 87.27 crore in FY2024.
  • Total borrowings rose to Rs 1,393.86 crore as on 31 March 2026 from Rs 923.92 crore in FY2024 against a net worth of Rs 394.94 crore, and the debt to equity ratio was 3.53 times.
  • Attrition among doctors, nurses and support staff was 60.38% in FY2026, 66.74% in FY2025 and 65.27% in FY2024.
  • Five of the eight hospitals are in North India and gave 66.07% of FY2026 revenue from operations, so one region drives most of the business.
  • CONGOR specialties gave 74.70% of FY2026 revenue from operations, so demand for six clinical lines decides the top line.
  • Government schemes and public sector undertakings now pay for 41.28% of revenue against 29.76% in FY2024, while self pay fell to 33.88% from 40.63%, and the company says its scheme empanelments have faced suspension and temporary restrictions in the past.
  • Six of the eight hospitals run on leased premises, five under revenue share and long-term lease arrangements and one under a public private partnership, so renewal terms are outside the company's control.
  • The offer for sale is Rs 950.00 crore of the Rs 1,450.00 crore offer, and only Rs 500.00 crore is fresh money for the company. The promoter is selling Rs 300.00 crore of shares and Commelina Ltd is selling Rs 650.00 crore, as per the estimated amounts shown at the source.
  • Average revenue per occupied bed slipped to Rs 47,397.82 per day in FY2026 from Rs 48,088.57 in FY2025, with Srinagar falling to Rs 36,532.56 from Rs 62,401.30, so occupancy rather than pricing drove the growth.

Source-provided company information. Read the RHP for the complete risk factors; these points are not a recommendation.

Listing performance

Listing price₹720
Listing day gain+3.9%
Current market price₹834.95
Current gain vs IPO+20.48%

Actual listing figures appear after listing. Current gain is source-adjusted for corporate actions. CMP is a source snapshot, not a streaming quote.

Official documents, registrar & contacts

Offer documents

Red Herring Prospectus (RHP)
Draft Prospectus (DRHP)
Anchor Allocation
Read Anchor Doc: not published
Basis of Allotment
Registrar & Allotment

MUFG Intime India Private Limited

Phone: 022-49186000

Email: parashealthcare.ipo@in.mpms.mufg.com

Allotment date: 26 Oct 2026

Book Running Lead Managers
  • •JM Financial Ltd.
  • •Nuvama Wealth Management Ltd.
  • •Bofa Securities India Limited
Company Registered Office

1st Floor, Tower B, Paras Twin Towers, Golf Course Road, Sector 54, Gurugram 122 002, Haryana, India

Phone: +91 124 430 2163

Email: cs@parashospitals.com

Continue your IPO research

Explore more IPO companies

Related by issue type, with active issues first. These are research links, not investment recommendations.

IPO data by StockeZee · Prices in INR · Times in IST

GMP is an unofficial, unregulated market signal. Issue price + GMP is an arithmetic reference, not a listing forecast or assured return. Subscription does not guarantee allotment. Read the offer documents and company risks before investing.